FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

35408011000036106: eye gel dose form (AU qualifier)

Status: current, Primitive. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
170401011000036113 eye gel en Synonym Active Case sensitive Australian Medicines Terminology module
170402011000036119 eye gel dose form (AU qualifier) en Fully specified name Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
eye gel Is a form true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
polyethylene glycol-400 0.4% + propylene glycol 0.3% eye gel has manufactured dose form False eye gel Inferred relationship Some
Systane 0.4% / 0.3% Gel Drops eye gel has manufactured dose form False eye gel Inferred relationship Some
macrogol-400 0.4% + propylene glycol 0.3% eye gel has manufactured dose form True eye gel Inferred relationship Some
Systane 0.4% / 0.3% Gel Drops eye gel has manufactured dose form True eye gel Inferred relationship Some
carbomer 0.2% + triglyceride lipids 1% eye gel has manufactured dose form False eye gel Inferred relationship Some
carbomer 0.2% + triglyceride lipids 1% eye gel, unit dose has manufactured dose form False eye gel Inferred relationship Some
carmellose sodium 1% eye gel, unit dose has manufactured dose form True eye gel Inferred relationship Some
carbomer-974 0.3% eye gel, unit dose has manufactured dose form False eye gel Inferred relationship Some
carbomer-980 0.2% eye gel has manufactured dose form True eye gel Inferred relationship Some
timolol 0.1% eye gel has manufactured dose form True eye gel Inferred relationship Some
PAA 0.2% eye gel has manufactured dose form True eye gel Inferred relationship Some
Artelac 0.2% / 1% eye gel has manufactured dose form False eye gel Inferred relationship Some
HPMC PAA 0.3% / 0.2% eye gel has manufactured dose form True eye gel Inferred relationship Some
Nyogel 0.1% eye gel has manufactured dose form True eye gel Inferred relationship Some
hypromellose 0.3% + carbomer-980 0.2% eye gel has manufactured dose form True eye gel Inferred relationship Some
Genteal Gel 0.3% / 0.2% eye gel has manufactured dose form True eye gel Inferred relationship Some
Optifresh 0.2% eye gel has manufactured dose form True eye gel Inferred relationship Some
Artelac 0.2% / 1% eye gel, 600 mg unit dose has manufactured dose form False eye gel Inferred relationship Some
Viscotears Liquid 0.2% eye gel has manufactured dose form True eye gel Inferred relationship Some
Theratears Liquid 1% eye gel, 0.6 mL unit dose has manufactured dose form True eye gel Inferred relationship Some
Poly Gel 0.3% eye gel, 500 mg unit dose has manufactured dose form False eye gel Inferred relationship Some
Geltears 0.2% eye gel has manufactured dose form True eye gel Inferred relationship Some
Poly Gel 0.3% eye gel, 500 mg unit dose has manufactured dose form True eye gel Inferred relationship Some
carbomer-974P 0.3% eye gel, unit dose has manufactured dose form True eye gel Inferred relationship Some
carbomer-980 0.2% + triglyceride lipids 1% eye gel has manufactured dose form True eye gel Inferred relationship Some
carbomer-980 0.2% + triglyceride lipids 1% eye gel, unit dose has manufactured dose form True eye gel Inferred relationship Some
Artelac 0.2% / 1% (carbomer-980 2 mg / 1 g + triglyceride lipids 10 mg / 1 g) eye gel (trade product unit of use) has manufactured dose form True eye gel Inferred relationship Some
Artelac 0.2% / 1% eye gel, 600 mg unit dose has manufactured dose form True eye gel Inferred relationship Some

This concept is not in any reference sets

Back to Start